-+ 0.00%
-+ 0.00%
-+ 0.00%

Akari Therapeutics Appoints Abizer Gaslightwala As President And CEO

Benzinga·03/20/2025 12:37:13
Listen to the news

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning both solid and hematological malignancies that have total annual sales of $1B

Held several executive leadership roles at Amgen, Pfizer, and Johnson & Johnson across multiple brands including Kyprolis®, Vectibix®, Neulasta®, XGEVA®, Repatha®, and ELIQUIS®

Current President and CEO, Samir R. Patel, M.D., to remain as a member of the Company's Board of Directors